Tag: TasP

Response to Treatment by Prevention Article The Globe and Mail article: B.C. medical researchers offer treatment by prevention for hepatitis C PHCN recognizes treatment as prevention (TasP) as the strategy of choice for people who use injection/inhalation drugs, who, as a group, have the highest rate of new HCV infections. Treatment as prevention is an… Read more »

The BC Centre for Excellence in HIV/AIDS (BC-CfE) has signed a Memorandum of Understanding (MOU) that will see Queensland, Australia, embrace the made-in-B.C. HIV Treatment as Prevention (TasP) strategy. BC-CfE, the Government of Queensland and HIV Foundation Queensland (HIVFQ) signed the agreement at the 20th International AIDS Conference in Melbourne. The partnership formalizes a collaboration… Read more »

In this guest blog post, CATIE’s James Wilton explores the challenges and opportunities in moving research around new HIV prevention technologies into practice, highlighting the important role of community based organizations in implementing new approaches to HIV prevention and in doing community-based research to evaluate new models of intervention. ——————————————————————————————————- Moving research on new “biomedical”… Read more »